Neurocutaneous Syndromes 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neurocutaneous Syndromes
NCT00652990: Sirolimus to Treat Plexiform Neurofibromas in Patients With Neurofibromatosis Type I

Active, not recruiting
2
18
US
Sirolimus
University of Alabama at Birmingham, National Cancer Institute (NCI)
Neurofibromatosis Type 1, Plexiform Neurofibromas, Paraspinal Plexiform Neurofibromas
08/14
08/14
NCT00678951: Pegintron to Treat Plexiform Neurofibromas in Children and Young Adults

Recruiting
2
90
US
PEG-interferon alfa-2b, MRI
National Cancer Institute (NCI)
Neurofibromatosis Type 1, Plexiform Neurofibroma
01/16
01/16

Download Options